Equality and Human Rights Consultation - NICE TA - Pemetrexed Maintenance Treatment following Induction Therapy with Pemetrexed and Cisplatin for Non-Squamous Non-Small-Cell Lung Cancer (Review of TA309)

Consultation opened on 20 July 2016. Closing date 30 August 2016.


NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the Department established links with NICE whereby all technology appraisals and clinical guidelines published from that date are locally reviewed for applicability to Northern Ireland and, where appropriate, are endorsed for implementation in health and social care. THE LOCAL REVIEW DOES NOT REASSESS THE CLINICAL AND COST EVIDENCE USED BY NICE IN FORMING ITS ADVICE. This link has ensured that Northern Ireland has access to up-to-date, independent, professional, evidence-based guidance on the value of health care interventions.


Consultation description

Guidance for the consultation can be found on the NICE website

The HSC (SQSD) 2/13 circular provides details of the process for the endorsement, implementation, monitoring and assurance of NICE Technology Appraisals in Northern Ireland.

In order to meet the timescales set out in the circular, the closing date for responses is Tuesday 30th August 2016.

This will inform the Equality Screening.

Share this consultation

Back to top